泰林生物收盘上涨3.52%，滚动市盈率216.23倍，总市值23.15亿元

Company Overview - Zhejiang Tailin Biological Technology Co., Ltd. specializes in microbial testing and pollution control, innovative drug research and production, and process analysis, providing high-quality products and solutions for the biopharmaceutical, healthcare, food and beverage, and environmental protection industries [2] Financial Performance - For Q1 2025, the company reported revenue of 66.939 million yuan, a year-on-year decrease of 16.33%, and a net profit of 3.5282 million yuan, down 39.93%, with a gross profit margin of 49.27% [2] Market Position - As of May 19, the company's stock closed at 19.1 yuan, up 3.52%, with a rolling PE ratio of 216.23, marking a new low in 29 days. The total market capitalization is 2.315 billion yuan [1] - The average PE ratio in the medical device industry is 49.26, with a median of 36.71, placing Tailin Biological at the 117th position in the industry ranking [1][3] Shareholder Information - As of March 31, 2025, the number of shareholders is 11,553, a decrease of 294 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares per shareholder [1]